<p id="hl0000088" class="ng-scope">Editorial Comment</p> <p id="hl0000089" class="ng-scope">We have read with interest the comment by Chaudhuri and colleagues on our recent paper describing the complications of MANTA closure device (Teleflex, PA, USA) reported to the FDA<span> </span><button class="j-inline-reference inline-reference" data-refid="bb0005" id="refInSitubb0005">[1]</button><span> </span>. The authors make a valid point on the need for more literature on using MANTA by vascular surgery during endovascular aortic aneurysm repair procedures. However, it should be noted that endovascular procedures represented 20% of patients in the SAFE MANTA study<span> </span><button class="j-inline-reference inline-reference" data-refid="bb0010" id="refInSitubb0010">[2]</button><span> </span>. They also describe their successful use of the device while being prospectively audited. We cannot agree more with the points made by the authors on the importance of meticulous techniques for access and closure to avoid the complications of MANTA mentioned in the original manuscript.</p>